包涵体肌炎的生存率及相关合并症研究
基于罗切斯特流行病学项目的人群病例对照研究,纳入50例包涵体肌炎(IBM)、65例其他特发性炎性肌病(IIM)和294例人群对照,发现IBM患者10年生存率仅36%,且周围神经病、干燥综合征和血液系统恶性肿瘤风险显著高于人群对照。
要点
- IBM患者10年生存率36%,显著低于IIM的67%和人群对照的59%。
- IBM患者周围神经病、干燥综合征和血液系统恶性肿瘤风险分别是对照的2.7、6.2和3.9倍。
- 呼吸衰竭或肺炎是IBM最常见死因(44%),需密切监测相关并发症。
核心结论
- IBM与较低生存率相关,且周围神经病、干燥综合征和血液系统恶性肿瘤频率高于一般人群。
- 需密切监测IBM相关并发症。
研究设计与样本
- 基于罗切斯特流行病学项目医疗记录 linkage 系统的人群病例对照研究,覆盖明尼苏达和威斯康星州27个县。
- 纳入50例IBM患者、65例其他炎性肌病(IIM)对照和294例年龄性别匹配的人群对照。
主要发现
- 吞咽困难在IBM患者中最常见(64%)。
- 神经退行性疾病(痴呆/帕金森综合征)和实体癌频率组间无差异。
- 类风湿关节炎在所有组中均为最常见风湿病。
- 36%的IBM患者有周围神经病,6%有干燥综合征,10%有血液系统恶性肿瘤。
- T细胞大颗粒淋巴细胞白血病仅在IBM组中观察到;IBM患者中无乙肝、丙肝或HIV感染。
临床怎么用
- 对IBM患者应密切监测周围神经病、干燥综合征和血液系统恶性肿瘤等并发症。
- 关注IBM患者的呼吸功能及感染风险,因呼吸衰竭或肺炎为最常见死因。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate survival and associated comorbidities in inclusion body myositis (IBM) in a population-based, case-control study. METHODS: We utilized the expanded Rochester Epidemiology Project medical records-linkage system, including 27 counties in Minnesota and Wisconsin, to identify patients with IBM, other inflammatory myopathies (IIM), and age/sex-matched population-controls. We compared the frequency of various comorbidities and survival among groups. RESULTS: We identified 50 IBM patients, 65 IIM controls and 294 population controls. Dysphagia was most common in IBM (64%) patients. The frequency of neurodegenerative disorders (dementia/parkinsonism) and solid cancers was not different between groups. Rheumatoid arthritis was the most common rheumatic disease in all groups. A total of 36% of IBM patients had a peripheral neuropathy, 6% had Sjögren's syndrome and 10% had a haematologic malignancy. T-cell large granular lymphocytic leukaemia was only observed in the IBM group. None of the IBM patients had hepatitis B or C, or HIV. IBM patients were 2.7 times more likely to have peripheral neuropathy, 6.2 times more likely to have Sjögren's syndrome and 3.9 times more likely to have a haematologic malignancy than population controls. IBM was associated with increased mortality, with a 10-year survival of 36% from index, compared with 67% in IIM and 59% in population controls. Respiratory failure or pneumonia (44%) was the most common cause of death. CONCLUSIONS: IBM is associated with lower survival, and higher frequency of peripheral neuropathy, Sjögren's syndrome and haematologic malignancies than the general population. Close monitoring of IBM-related complications is warranted.
引用
- Naddaf E, Shelly S, Mandrekar J, et al. Survival and associated comorbidities in inclusion body myositis. Rheumatology (Oxford). 2022. PMID: 34534271. doi:10.1093/rheumatology/keab716
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。